Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARP1 | P09874 | 16/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.45 |
| ▸ | HPGD | P15428 | 2/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7243980 | 0.73 | HPGD (0.45) | PARP1CYP1A2HPGDCYP2C9KDM4E | |
| SCHEMBL6068824 | 0.72 | MAPT (0.38) | KDM4EALDH1A1RAB9A | |
| SCHEMBL6068830 | 0.71 | RXFP1 (0.50) | KDM4EALDH1A1 | |
| SCHEMBL6068481 | 0.71 | POLB (0.46) | HPGDKDM4EALDH1A1 | |
| SCHEMBL6068520 | 0.69 | HPGD (0.51) | HPGDKDM4EALDH1A1 | |
| SCHEMBL6068521 | 0.69 | KDM4E (0.41) | HPGDKDM4EALDH1A1 | |
| SCHEMBL6068805 | 0.67 | MAPT (0.41) | KDM4EALDH1A1RAB9A | |
| SCHEMBL6068610 | 0.67 | POLB (0.44) | HPGDKDM4EALDH1A1 | |
| SCHEMBL6068240 | 0.66 | MAPT (0.40) | KDM4EALDH1A1RAB9A | |
| SCHEMBL21995479 | 0.66 | HPGD (0.44) | PARP1CYP1A2HPGDCYP2C9KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7144887-B2 | Substituted 1,2,3-triazolo[1,5-a]quinazolines for enhancing cognition | MERCK SHARP & DOHME LTD. (GB) | 2006-12-05 | — | — | US | disclosed |